Usona Institute
Usona Institute
Explore linked clinical trials.12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy | peripheral neuropathy | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07227909 | |
| Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder | Recruiting | Phase 1 | 2026-09-04 | NCT06430541 | |
| Effects of Psilocybin in Obsessive Compulsive Disorder | anxiety disorder, obsessive-compulsive disorder, psychiatric disorder | Active, not recruiting | Early phase 1 | 2026-09-04 | NCT05546658 | |
| Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life | Aging; Biomarkers of Aging; Longevity | Not yet recruiting | Phase 1 | 2026-08-17 | NCT07719088 | |
| Psilocybin to Treat Depression in Spinal Cord Injury | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, depressive disorder, injury, nervous system disorder, nervous system injury, neuralgia, neuromuscular disease, palsy, paraplegia, peripheral nervous system disorder, quadriplegia, spinal cord disorder, spinal cord injury | Recruiting | Phase 1 / Phase 2 | 2026-08-10 | NCT07251491 | |
| Investigation to Understand and Optimize Psilocybin | depressive disorder | Recruiting | Phase 2 | 2026-08-10 | NCT06512194 | |
| Psilocybin for Major Depressive Disorder (MDD) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-07-23 | NCT06308653 | |
| A Study of Psilocybin for PTSD | Stress Disorders, Traumatic, acute stress disorder, post-traumatic stress disorder, psychiatric disorder | Active, not recruiting | Phase 1 | 2026-06-22 | NCT06407635 | |
| Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-03-13 | NCT04620759 | |
| Open-Label Psilocybin Study in Transdiagnostic Population | Chemically-Induced Disorders, Stress Disorders, Traumatic, Substance Use, acute stress disorder, anxiety, anxiety disorder, depressive disorder, obsessive-compulsive personality disorder, post-traumatic stress disorder, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 | 2026-03-11 | NCT06442423 | |
| Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability | Hemorrhage, Infarction, Intracranial Hemorrhages, Necrosis, Neurologic Manifestations, Paresis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, hemiplegia, hemorrhagic stroke, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, ischemic stroke, middle cerebral artery infarction, nervous system disorder, palsy, stroke disorder, vascular disorder | Recruiting | Phase 1 | 2026-02-13 | NCT07053917 | |
| State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma | Stress Disorders, Traumatic, acute stress disorder, injury, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-01-22 | NCT06888128 |